Serum TSH and Risk of Papillary Thyroid Cancer in Nodular Thyroid Disease

Journal of Clinical Endocrinology and Metabolism - Tập 97 Số 4 - Trang 1134-1145 - 2012
Emilio Fiore1, Paolo Vitti2
1Department of Endocrinology and Metabolism, University of Pisa, via Paradisa 2, 56100 Pisa, Italy.
2Department of Endocrinology and Metabolism, University of Pisa, 56100 Pisa, Italy

Tóm tắt

Context: TSH is the main factor involved in the control of proliferation of thyrocytes. Recently, a strong relationship between serum TSH and risk of thyroid malignancy has been reported. Objectives: The aim was to review published papers about the relationship between serum TSH and frequency of differentiated thyroid cancer. Evidence Acquisition: PubMed was used to identify studies focused on the relationship between TSH and differentiated thyroid cancer. Evidence Synthesis: In patients with nodular thyroid disease, the risk of thyroid malignancy increases with serum TSH, and even within normal ranges, higher TSH values are associated with a higher frequency and more advanced stage of thyroid cancer. The likelihood of papillary thyroid carcinoma is reduced when TSH is lower, as in thyroid autonomy, and increased when TSH is higher, as in thyroid autoimmunity. Treatment with l-thyroxine (LT4), which reduces serum TSH, is associated with significantly lower risk of developing clinically detectable thyroid cancer. Conclusions: TSH plays a key role in the development of clinically detectable thyroid cancer, and LT4 treatment reduces the risk of thyroid malignancy in patients with nodular thyroid disease. According to the guidelines of the main scientific societies, LT4 therapy is not currently recommended for the treatment of patients with nodular goiter. Even if the available data are not sufficient to advise LT4 treatment in all patients with nodular goiter with the aim of reducing the risk of papillary thyroid carcinoma, we propose that this indication should be reconsidered, taking into account recent evidence reported in the literature.

Từ khóa


Tài liệu tham khảo

Hegedüs, 2004, Clinical practice. The thyroid nodule., N Engl J Med, 351, 1764, 10.1056/NEJMcp031436

Tunbridge, 1977, The spectrum of thyroid disease in a community: the Whickham survey., Clin Endocrinol (Oxf), 7, 481, 10.1111/j.1365-2265.1977.tb01340.x

Vander, 1968, The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy., Ann Intern Med, 69, 537, 10.7326/0003-4819-69-3-537

Hegedüs, 2001, Thyroid ultrasound., Endocrinol Metab Clin North Am, 30, 339, 10.1016/S0889-8529(05)70190-0

Knudsen, 2002, Risk factors for goiter and thyroid nodules., Thyroid, 12, 879, 10.1089/105072502761016502

Marqusee, 2000, Usefulness of ultrasonography in the management of nodular thyroid disease., Ann Intern Med, 133, 696, 10.7326/0003-4819-133-9-200011070-00011

Reiners, 2004, Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees., Thyroid, 14, 926, 10.1089/thy.2004.14.926

Davies, 2006, Increasing incidence of thyroid cancer in the United States, 1973–2002., JAMA, 295, 2164, 10.1001/jama.295.18.2164

Yu, 2010, Thyroid cancer incidence and survival in the National Cancer Institute surveillance, epidemiology, and end results race/ethnicity groups., Thyroid, 20, 465, 10.1089/thy.2008.0281

Pacini, 2006, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium., Eur J Endocrinol, 154, 787, 10.1530/eje.1.02158

Belfiore, 1992, Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity., Am J Med, 93, 363, 10.1016/0002-9343(92)90164-7

Hegedüs, 2003, Management of simple nodular goiter: current status and future perspectives., Endocr Rev, 24, 102, 10.1210/er.2002-0016

Morganti, 2005, Thyroid disease in the elderly: sex-related differences in clinical expression., J Endocrinol Invest, 28, 101

Polyzos, 2007, Thyroid nodules—stepwise diagnosis and management., Hormones (Athens), 6, 101, 10.14310/horm.2002.111107

Tuttle, 1998, Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration., Thyroid, 8, 377, 10.1089/thy.1998.8.377

Rago, 2010, Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease., Eur J Endocrinol, 162, 763, 10.1530/EJE-09-0895

Boelaert, 2006, Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration., J Clin Endocrinol Metab, 91, 4295, 10.1210/jc.2006-0527

Fiore, 2009, Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role., Endocr Relat Cancer, 16, 1251, 10.1677/ERC-09-0036

Frates, 2006, Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography., J Clin Endocrinol Metab, 91, 3411, 10.1210/jc.2006-0690

Nosé, 2010, Familial follicular cell tumors: classification and morphological characteristics., Endocr Pathol, 21, 219, 10.1007/s12022-010-9135-6

Castro, 2003, Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls., Endocr Pract, 9, 128, 10.4158/EP.9.2.128

Gharib, 1997, Changing concepts in the diagnosis and management of thyroid nodules., Endocrinol Metab Clin North Am, 26, 777, 10.1016/S0889-8529(05)70282-6

Burch, 1995, Evaluation and management of the solid thyroid nodule., Endocrinol Metab Clin North Am, 24, 663, 10.1016/S0889-8529(18)30019-7

Cersosimo, 1993, “Suspicious” thyroid cytologic findings: outcome in patients without immediate surgical treatment., Mayo Clin Proc, 68, 343, 10.1016/S0025-6196(12)60128-1

Chow, 2001, Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas., Thyroid, 11, 1147, 10.1089/10507250152740993

Tan, 1995, Solitary thyroid nodule. Comparison between palpation and ultrasonography., Arch Intern Med, 155, 2418, 10.1001/archinte.1995.00430220076008

Jonklaas, 2008, Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer., Thyroid, 18, 943, 10.1089/thy.2008.0061

Polyzos, 2008, Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules., J Cancer Res Clin Oncol, 134, 953, 10.1007/s00432-008-0373-7

Haymart, 2008, Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage., J Clin Endocrinol Metab, 93, 809, 10.1210/jc.2007-2215

Haymart, 2009, Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension., Clin Endocrinol (Oxf), 71, 434, 10.1111/j.1365-2265.2008.03489.x

Jin, 2010, The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease., Am J Surg, 199, 294, 10.1016/j.amjsurg.2009.08.028

Gerschpacher, 2010, Thyrotropin serum concentrations in patients with papillary thyroid microcancers., Thyroid, 20, 389, 10.1089/thy.2009.0139

Kimura, 2001, Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models., Endocr Rev, 22, 631, 10.1210/edrv.22.5.0444

Tonacchera, 1996, TSH receptor and disease., Clin Endocrinol (Oxf), 44, 621, 10.1046/j.1365-2265.1996.746567.x

Ledent, 1991, The TSH cyclic AMP cascade in the control of thyroid cell proliferation: the story of a concept., Thyroidology, 3, 97

Schaller, 1966, Development of carcinoma of the thyroid in iodine-deficient mice., Cancer, 19, 1063, 10.1002/1097-0142(196608)19:8<1063::AID-CNCR2820190804>3.0.CO;2-A

Fortner, 1960, Induced and spontaneous thyroid cancer in the Syrian (golden) hamster., Endocrinology, 6, 364, 10.1210/endo-66-3-364

Farid, 1994, Molecular basis of thyroid cancer., Endocr Rev, 15, 202

Wynford-Thomas, 1993, Molecular genetics of thyroid cancer., Trends Endocrinol Metab, 4, 224, 10.1016/1043-2760(93)90126-Y

Feldt-Rasmussen, 2001, Iodine and cancer., Thyroid, 11, 483, 10.1089/105072501300176435

Biondi, 2005, Thyroid-hormone therapy and thyroid cancer: a reassessment., Nat Clin Pract Endocrinol Metab, 1, 32, 10.1038/ncpendmet0020

Mazzaferri, 1999, An overview of the management of papillary and follicular thyroid carcinoma., Thyroid, 9, 421, 10.1089/thy.1999.9.421

Sipos, 2008, The therapeutic management of differentiated thyroid cancer., Expert Opin Pharmacother, 9, 2627, 10.1517/14656566.9.15.2627

Schlumberger, 1998, Papillary and follicular thyroid carcinoma., N Engl J Med, 338, 297, 10.1056/NEJM199801293380506

Ciampi, 2007, RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis., Endocrinology, 148, 936, 10.1210/en.2006-0921

Nikiforova, 2008, Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis., Expert Rev Mol Diagn, 8, 83, 10.1586/14737159.8.1.83

Franco, 2011, Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice., Proc Natl Acad Sci USA, 108, 1615, 10.1073/pnas.1015557108

Kumar, 1999, Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology., Thyroid, 9, 1105, 10.1089/thy.1999.9.1105

Fiore, 2011, Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine., Endocr Relat Cancer, 18, 429, 10.1530/ERC-11-0028

Zafon, 2012, Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas, then to papillary thyroid cancers of larger size., J Thyroid Res, 2012, 530721, 10.1155/2012/530721

Gul, 2010, Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?, Endocrine, 37, 253, 10.1007/s12020-010-9316-6

Hands, 2010, Enlarged benign-appearing cervical lymph nodes by ultrasonography are associated with increased likelihood of cancer somewhere within the thyroid in patients undergoing thyroid nodule evaluation., Thyroid, 20, 857, 10.1089/thy.2009.0464

Kim, 2011, Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis., Head Neck, 33, 691, 10.1002/hed.21518

Castro, 2011, Predictors of malignancy in patients with cytologically suspicious thyroid nodules., Thyroid, 21, 1191, 10.1089/thy.2011.0146

Derwahl, 2001, Nodular goiter and goiter nodules: where iodine deficiency falls short of explaining the facts., Exp Clin Endocrinol Diabetes, 109, 250, 10.1055/s-2001-16344

Studer, 1989, Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth., Endocr Rev, 10, 125, 10.1210/edrv-10-2-125

Aghini-Lombardi, 1999, The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey., J Clin Endocrinol Metab, 84, 561

Fenzi, 1985, Reciprocal changes of serum thyroglobulin and TSH in residents of a moderate endemic goitre area., Clin Endocrinol (Oxf), 23, 115, 10.1111/j.1365-2265.1985.tb00205.x

Vitti, 1990, Thyroid autoimmunity and thyroid autonomy., Acta Med Austriaca, 17, 90

Hollowell, 2002, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)., J Clin Endocrinol Metab, 87, 489, 10.1210/jcem.87.2.8182

Aoki, 2007, Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002)., Thyroid, 17, 1211, 10.1089/thy.2006.0235

Surks, 2007, Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism., J Clin Endocrinol Metab, 92, 4575, 10.1210/jc.2007-1499

Ngan, 2009, A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma., J Natl Cancer Inst, 101, 162, 10.1093/jnci/djn471

Gudmundsson, 2009, Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations., Nat Genet, 41, 460, 10.1038/ng.339

Kim, 2011, Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience., Endocrine, 39, 259, 10.1007/s12020-010-9430-5

Dailey, 1955, Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland., AMA Arch Surg, 70, 291, 10.1001/archsurg.1955.01270080137023

Hirabayashi, 1965, The relation of thyroid carcinoma and chronic thyroiditis., Surg Gynecol Obstet, 121, 243

Ott, 1987, The incidence of thyroid carcinoma in Hashimoto's thyroiditis., Am Surg, 53, 442

Ott, 1985, The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules., Surgery, 98, 1202

Okayasu, 1997, The relationship of lymphocytic thyroiditis to the development of thyroid carcinoma., Endocr Pathol, 8, 225, 10.1007/BF02738789

Okayasu, 1995, Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans., Cancer, 76, 2312, 10.1002/1097-0142(19951201)76:11<2312::AID-CNCR2820761120>3.0.CO;2-H

Mizukami, 1992, Carcinoma of the thyroid at a young age—a review of 23 patients., Histopathology, 20, 63, 10.1111/j.1365-2559.1992.tb00918.x

McConahey, 1986, Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome., Mayo Clin Proc, 61, 978, 10.1016/S0025-6196(12)62641-X

Singh, 1999, Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome., Surgery, 126, 1070, 10.1067/msy.2099.101431

Baker, 1995, The immune response to papillary thyroid cancer., J Clin Endocrinol Metab, 80, 3419

Crile, 1962, Incidence of cancer in struma lymphomatosa., Surg Gynecol Obstet, 115, 101

Holm, 1985, Cancer risks in patients with chronic lymphocytic thyroiditis., N Engl J Med, 312, 601, 10.1056/NEJM198503073121001

Boi, 2005, High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies., Eur J Endocrinol, 153, 637, 10.1530/eje.1.02020

Fiore, 2009, Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases., J Endocrinol Invest, 32, 344, 10.1007/BF03345725

Vanderpump, 1995, The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey., Clin Endocrinol (Oxf), 43, 55, 10.1111/j.1365-2265.1995.tb01894.x

Walsh, 2010, Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques., J Clin Endocrinol Metab, 95, 1095, 10.1210/jc.2009-1977

Mariotti, 1990, Antithyroid peroxidase autoantibodies in thyroid diseases., J Clin Endocrinol Metab, 71, 661, 10.1210/jcem-71-3-661

Knobel, 1994, Prevalence of anti-thyroid peroxidase antibodies in autoimmune and nonautoimmune thyroid disorders in a relatively low-iodine environment., J Endocrinol Invest, 17, 837, 10.1007/BF03347788

Marcocci, 1991, Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism., J Clin Endocrinol Metab, 72, 209, 10.1210/jcem-72-1-209

Rago, 2001, Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects., J Endocrinol Invest, 24, 763, 10.1007/BF03343925

Kim, 2010, Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules., Thyroid, 20, 885, 10.1089/thy.2009.0384

Latrofa, 2010, Characterization of thyroglobulin epitopes in Sardinian adults and juveniles with Hashimoto's thyroiditis: evidence against a major effect of age and genetic background on B-cell epitopes., Clin Endocrinol (Oxf), 73, 110, 10.1111/j.1365-2265.2009.03748.x

Mazzaferri, 1994, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer., Am J Med, 97, 418, 10.1016/0002-9343(94)90321-2

Goldberg, 1964, Induction of neoplasms in thyroid glands of rats by subtotal thyroidectomy and by the injection of one microcurie of I-131., Cancer Res, 24, 35

Gharib, 2010, American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations., Endocr Pract, 16, 468, 10.4158/EP.16.3.468

Cooper, 2006, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer., Thyroid, 16, 109, 10.1089/thy.2006.16.109

Fiore, 2010, L-Thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27,914 patients., Endocr Relat Cancer, 17, 231, 10.1677/ERC-09-0251

La Rosa, 1995, Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid., Ann Intern Med, 122, 1, 10.7326/0003-4819-122-1-199501010-00001

Sdano, 2005, Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials., Otolaryngol Head Neck Surg, 133, 391, 10.1016/j.otohns.2005.06.007

Lima, 1997, Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters., Thyroid, 7, 691, 10.1089/thy.1997.7.691

Berghout, 1990, Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre., Lancet, 336, 193, 10.1016/0140-6736(90)91730-X

Wesche, 2001, A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter., J Clin Endocrinol Metab, 86, 998, 10.1210/jcem.86.3.7244

Castro, 2002, Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis., J Clin Endocrinol Metab, 87, 4154, 10.1210/jc.2001-011762

Gharib, 1987, Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study., N Engl J Med, 317, 70, 10.1056/NEJM198707093170202

Reverter, 1992, Suppressive therapy with levothyroxine for solitary thyroid nodules., Clin Endocrinol (Oxf), 36, 25, 10.1111/j.1365-2265.1992.tb02898.x

Zelmanovitz, 1998, Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses., J Clin Endocrinol Metab, 83, 3881

Larijani, 1999, Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial., Endocr Pract, 5, 251, 10.4158/EP.5.5.251

Wémeau, 2002, Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group., J Clin Endocrinol Metab, 87, 4928, 10.1210/jc.2002-020365

Papini, 1993, A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules., Clin Endocrinol (Oxf), 38, 507, 10.1111/j.1365-2265.1993.tb00347.x

Biondi, 2008, The clinical significance of subclinical thyroid dysfunction., Endocr Rev, 29, 76, 10.1210/er.2006-0043

Sawin, 1994, Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons., N Engl J Med, 331, 1249, 10.1056/NEJM199411103311901

Heijckmann, 2005, Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma., Eur J Endocrinol, 153, 23, 10.1530/eje.1.01933

Williams, 1997, Adverse effects of thyroid hormones., Drugs Aging, 11, 460, 10.2165/00002512-199711060-00005

Thông tin
Thông tin xuất bản

Journal of Clinical Endocrinology and Metabolism

Tập 97 Số 4

1134-1145

Thông tin tác giả